RNTX RNTX Facilities And Other Expenses — Research And Development Expense

Other product segments

Similar metrics at other companies

TYRAFacilities And Other Costs — Research And Development Expense

$1.63M+16.3%

TNGXFacilities And Other Related Expenses-RD — Research And Development Expense

$4.34M-20.6%

IRONOther Research — Research And Development Expense

$2.17M+18.2%

DBVTExpenses by function — Research and development expense

$8.5M+84.8%

STTKOther Research And Development — Other research and development expense

$1.9M+46.2%

DNTHOther Costs — Research And Development Expense

$1.49M+25.5%

Questions, answered.

What is RNTX's facilities and other expenses — research and development expense?

RNTX (RNTX) reported facilities and other expenses — research and development expense of $25K in Q1 2026.

How has RNTX's facilities and other expenses — research and development expense changed year-over-year?

RNTX's facilities and other expenses — research and development expense increased by 56.3% year-over-year, from $16K to $25K.

What is the long-term trend for RNTX's facilities and other expenses — research and development expense?

Over 2 years (2023 to 2025), RNTX's facilities and other expenses — research and development expense has grown at a 25.5% compound annual growth rate (CAGR), from $47K to $74K.

What does facilities and other expenses — research and development expense mean?

This metric represents the portion of research and development costs specifically allocated to the facilities and infrastructure segment of the company. It captures the operational overhead, maintenance, and utility expenses required to support clinical-stage drug development activities. Tracking this allows investors to assess the investment intensity in the physical environment necessary to advance the company's therapeutic pipeline.